Ignite Creation Date:
2024-05-05 @ 10:23 PM
Last Modification Date:
2024-10-26 @ 10:17 AM
Study NCT ID:
NCT01092104
Status:
COMPLETED
Last Update Posted:
2013-07-10
First Post:
2010-03-22
Brief Title:
A Proof of Concept Study to Evaluate the Antiviral Activity Safety and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected Antiretroviral Treatment-Experienced CCR5 Antagonist-Naïve Patients
Sponsor:
Organization:
Tobira Therapeutics Inc
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
52
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: